** Shares in healthcare companies drop on Wednesday as U.S. President Donald Trump is set to unveil his reciprocal tariff plans, which he deemed "Liberation Day"
** STOXX 600 Healthcare index .SXDP falls 2.5% to its lowest since December at 0819 GMT, leading sectoral losses on wider STOXX 600 .STOXX index, which is down 0.9%
** "This might be a reaction to the tariff announcements expected today from the U.S. administration, which this time could focus on the pharmaceutical sector," an analyst says
** "(...) it's not surprising that pharma stocks have been caught up in this wave of nervousness," Susannah Streeter, senior investment and markets analyst at Hargreaves Lansdown, says
** Among single stocks, Bayer BAYGn.DE and Sanofi SASY.PA fall 4.7% and 3.3%, respectively, while Lonza LONN.S and Novo Nordisk NOVOb.CO are down around 2.7%
** Novartis NOVN.S, Roche ROG.S and Merck MRCG.DE fall between 1.6% and 2.7%
** AstraZeneca AZN.L, Bavarian Nordic BAVA.CO, GSK GSK.L and UCB UCB.BR drop 2.5%-3.7%
(Reporting by Ozan Ergenay, Isabel Demetz, Sukriti Gupta)
((ozan.ergenay@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。